PART I (All monetary amounts are expressed in thousands of US dollars (unless stated otherwise), except for share and loss per share amounts.) On September 20, 2024, the Company implemented a 1-for-10 reverse stock split (the Reverse Split) of its authorized and outstanding shares of Common Stock. All share and per share amounts in these financial statements have been retroactively adjusted to reflect the Reverse Split as if it had been effected prior to the earliest financial statement period i...
Q2 FY2026 — expected 2026-09-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2024-12-31 | 0001493152-26-012845 | EDGAR | 94K words |
| 2024-04-15 | 2023-12-31 | 0001493152-24-014652 | EDGAR | — |
| 2023-03-22 | 2022-12-31 | 0001493152-23-008574 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001493152-22-008157 | EDGAR | — |
| 2021-03-09 | 2020-12-31 | 0001493152-21-005653 | EDGAR | — |
| 2020-03-09 | 2019-12-31 | 0001062993-20-001299 | EDGAR | — |
| 2019-02-13 | 2018-11-30 | 0001062993-19-000780 | EDGAR | — |
| 2018-02-28 | 2017-12-31 | 0001062993-18-001019 | EDGAR | — |
| 2017-02-28 | 2016-11-30 | 0001062993-17-001138 | EDGAR | — |
| 2016-02-29 | 2015-11-30 | 0001062993-16-008107 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2024-11-13 | 2024-09-30 | 0001493152-24-044972 | EDGAR | 33K words |
| 2024-08-08 | 2024-06-30 | 0001493152-24-030760 | EDGAR | — |
| 2024-05-20 | 2024-03-31 | 0001493152-24-020662 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040518 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001493152-23-027624 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001493152-23-016181 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001493152-22-031425 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001493152-22-022915 | EDGAR | — |
| 2022-05-23 | 2022-03-31 | 0001493152-22-014738 | EDGAR | — |
| 2021-11-04 | 2021-09-30 | 0001493152-21-027208 | EDGAR | — |
| 2021-08-05 | 2021-06-30 | 0001493152-21-018694 | EDGAR | — |
| 2021-05-06 | 2021-03-31 | 0001493152-21-010650 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-13 | 0001493152-26-010042 | EDGAR | 1K words |
| 2026-01-26 | 0001493152-26-003501 | EDGAR | — |
| 2025-09-16 | 0001493152-25-013758 | EDGAR | — |
| 2025-08-25 | 0001641172-25-025394 | EDGAR | — |
| 2025-08-19 | 0001641172-25-024840 | EDGAR | — |
| 2025-08-01 | 0001641172-25-021909 | EDGAR | — |
| 2025-06-06 | 0001641172-25-014075 | EDGAR | — |
| 2025-04-22 | 0001641172-25-005702 | EDGAR | — |
| 2025-03-06 | 0001493152-25-009380 | EDGAR | — |
| 2025-01-28 | 0001493152-25-003914 | EDGAR | — |
278 total filings indexed. 246 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001460602 |
| Ticker | ORGS |
| Exchange | — |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report